The function of brother of the regulator of imprinted sites in cancer development

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Cancer Gene Therapy

• Publication date

  2022-11-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/s41417-022-00556-0PMID 36376421
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy

  2022influential reference
• Genetic analysis of cancer drivers reveals cohesin and CTCF as suppressors of PD-L1

  2022cited by this paper
• BORIS-mediated generation of circular RNAs induces inflammation

  2022cited by this paper
• BORIS/CTCFL expression activates the TGFβ signaling cascade and induces Drp1 mediated mitochondrial fission in neuroblastoma.

  2021cited by this paper
• CTCFL expression is associated with cerebral vascular abnormalities.

  2021cited by this paper
• Pericentromeric noncoding RNA changes DNA binding of CTCF and inflammatory gene expression in senescence and cancer

  2021cited by this paper
• Novel Genetic and Molecular Pathways in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease

  2021cited by this paper
• The combined action of CTCF and its testis-specific paralog BORIS is essential for spermatogenesis

  2021cited by this paper
• Exploring the cancer-testis antigen BORIS to design a novel multi-epitope vaccine against breast cancer based on immunoinformatics approaches

  2021cited by this paper
• Single cell ATAC-Seq reveals cell type-specific transcriptional regulation and unique chromatin accessibility in human spermatogenesis.

  2021cited by this paper
• Downregulation of BORIS/CTCFL leads to ROS‐dependent cellular senescence and drug sensitivity in MYCN‐amplified neuroblastoma

  2021influential reference
• Immunoprotective effect of an in silico designed multiepitope cancer vaccine with BORIS cancer-testis antigen target in a murine mammary carcinoma model

  2021cited by this paper
• Construction of ceRNA network to identify the lncRNA and mRNA related to non-small cell lung cancer

  2021cited by this paper
• Expression profile of ACTL8, CTCFL, OIP5 and XAGE3 in glioma and their prognostic significance: a retrospective clinical study.

  2020cited by this paper
• Genomic amplification of chromosome 20q13.33 is the early biomarker for the development of sporadic colorectal carcinoma

  2020cited by this paper
• Brother of regulator of imprinted sites inhibits cisplatin-induced DNA damage in non-small cell lung cancer

  2020cited by this paper
• Dppa2 and Dppa4 counteract de novo methylation to establish a permissive epigenome for development

  2020cited by this paper
• Transcription Factor CTCFL Promotes Cell Proliferation, Migration, and Invasion in Gastric Cancer via Activating DPPA2

  2020influential reference
• CTCF mediates chromatin looping via N-terminal domain-dependent cohesin retention

  2020cited by this paper
• Pyruvate Kinase M2 and Cancer: The Role of PKM2 in Promoting Tumorigenesis

  2020cited by this paper
• Dietary-phytochemical mediated reversion of cancer-specific splicing inhibits Warburg effect in head and neck cancer

  2019cited by this paper
• Genome-wide bioinformatics analysis reveals CTCFL is upregulated in high-grade epithelial ovarian cancer

  2019influential reference
• Resistance to ALK Inhibitors in Neuroblastoma Is Regulated by BORIS.

  2019cited by this paper
• The epigenetic factor BORIS (CTCFL) controls the androgen receptor regulatory network in ovarian cancer

  2019cited by this paper
• BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells

  2019cited by this paper
• BORIS Expression in Ovarian Cancer Precursor Cells Alters the CTCF Cistrome and Enhances Invasiveness through GALNT14

  2019cited by this paper
• BORIS/CTCFL promotes a switch from a proliferative towards an invasive phenotype in melanoma cells

  2019influential reference
• Defining the relative and combined contribution of CTCF and CTCFL to genomic regulation

  2019cited by this paper
• Molecular basis of CTCF binding polarity in genome folding

  2019cited by this paper
• The expression of transcription factor BORIS and its association with the estrogen receptor beta (ER-β) in cervical carcinogenesis.

  2019cited by this paper
• MAGEA1 inhibits the expression of BORIS via increased promoter methylation

  2019cited by this paper
• Choice of binding sites for CTCFL compared to CTCF is driven by chromatin and by sequence preference

  2018cited by this paper
• BORIS: a key regulator of cancer stemness

  2018cited by this paper
• Short rare minisatellite variant of BORIS-MS2 is related to bladder cancer susceptibility

  2018cited by this paper
• Atractyloside mimics BORIS knockdown to induce DNA damage in colorectal cancer cells.

  2018cited by this paper
• Organizational principles of 3D genome architecture

  2018cited by this paper
• [BORIS Regulates SOCS3 Expression Through Epigenetic Mechanisms in Human Hepatocellular Carcinoma Cells].

  2018influential reference
• Modeling the process of human tumorigenesis

  2017cited by this paper
• Intragenic DNA methylation and BORIS-mediated cancer-specific splicing contribute to the Warburg effect

  2017cited by this paper
• Down-regulation of BORIS/CTCFL efficiently regulates cancer stemness and metastasis in MYCN amplified neuroblastoma cell line by modulating Wnt/β-catenin signaling pathway.

  2017cited by this paper
• Glucose Catabolism in Liver Tumors Induced by c-MYC Can Be Sustained by Various PKM1/PKM2 Ratios and Pyruvate Kinase Activities.

  2017cited by this paper
• BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells.

  2017cited by this paper
• The prognostic role of BORIS and SOCS3 in human hepatocellular carcinoma

  2017influential reference
• Discovering a binary CTCF code with a little help from BORIS

  2017cited by this paper
• Testis-specific transcriptional regulators selectively occupy BORIS-bound CTCF target regions in mouse male germ cells

  2017cited by this paper
• Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is a novel target of lung cancer stem-like cell immunotherapy

  2017cited by this paper
• Increased expression of brother of the regulator of imprinted sites in peripheral blood neutrophils is associated with both benign and malignant breast lesions

  2017cited by this paper
• Hypomethylation of BORIS is a promising prognostic biomarker in hepatocellular carcinoma.

  2017influential reference
• Brother of Regulator of Imprinted Sites (BORIS) suppresses apoptosis in colorectal cancer

  2017influential reference
• Transcriptional programs that control expression of the autoimmune regulator gene Aire

  2016cited by this paper
• A polymorphic minisatellite region of BORIS regulates gene expression and its rare variants correlate with lung cancer susceptibility

  2016cited by this paper
• The Warburg Effect: How Does it Benefit Cancer Cells?

  2016cited by this paper
• Spermatogenesis in humans and its affecting factors.

  2016cited by this paper
• The cancer-associated CTCFL/BORIS protein targets multiple classes of genomic repeats, with a distinct binding and functional preference for humanoid-specific SVA transposable elements

  2016cited by this paper
• Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy

  2016cited by this paper
• In Vitro Assessment of the Expression and T Cell Immunogenicity of the Tumor-Associated Antigens BORIS, MUC1, hTERT, MAGE-A3 and Sp17 in Uterine Cancer

  2016cited by this paper
• Comparative analyses of CTCF and BORIS occupancies uncover two distinct classes of CTCF binding genomic regions

  2015cited by this paper
• Expression of the CTCFL Gene during Mouse Embryogenesis Causes Growth Retardation, Postnatal Lethality, and Dysregulation of the Transforming Growth Factor β Pathway

  2015cited by this paper
• Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells

  2015cited by this paper
• BORIS and CTCF are overexpressed in squamous intraepithelial lesions and cervical cancer.

  2015cited by this paper
• Differential regulation of MAGE-A1 promoter activity by BORIS and Sp1, both interacting with the TATA binding protein

  2014cited by this paper
• High Expression of hTERT and Stemness Genes in BORIS/CTCFL Positive Cells Isolated from Embryonic Cancer Cells

  2014influential reference
• CTCFL (BORIS) mRNA Expression in a Peripheral Giant Cell Granuloma of the Oral Cavity

  2014cited by this paper
• Expression analysis of BORIS during pluripotent, differentiated, cancerous, and non-cancerous cell states.

  2014cited by this paper
• Possible Prognostic Value of BORIS Transcript Variants Ratio in Laryngeal Squamous Cell Carcinomas – a Pilot Study

  2014cited by this paper
• Expression of the cancer‐testis antigen BORIS correlates with prostate cancer

  2014cited by this paper
• The epigenetic factor BORIS/CTCFL regulates the NOTCH3 gene expression in cancer cells.

  2014cited by this paper
• Circulating cell-free cancer-testis MAGE-A RNA, BORIS RNA, let-7b and miR-202 in the blood of patients with breast cancer and benign breast diseases

  2014cited by this paper
• Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene

  2014cited by this paper
• Function of oncogenes in cancer development: a changing paradigm

  2013cited by this paper
• Expression of Cancer/Testis Antigens is Correlated with Improved Survival in Glioblastoma

  2013cited by this paper
• BORIS, Brother of the Regulator of Imprinted Sites, Is Aberrantly Expressed in Hepatocellular Carcinoma

  2013cited by this paper
• A Common Polymorphism within the IGF2 Imprinting Control Region Is Associated with Parent of Origin Specific Effects in Infantile Hemangiomas

  2013cited by this paper
• The male germ cell gene regulator CTCFL is functionally different from CTCF and binds CTCF-like consensus sites in a nucleosome composition-dependent manner

  2012cited by this paper
• Intronic Promoter Drives the BORIS-regulated Expression of FerT in Colon Carcinoma Cells*

  2012cited by this paper
• Cancer‐testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer

  2012cited by this paper
• BORIS in human cancers -- a review.

  2012cited by this paper
• A Cell Cycle Role for the Epigenetic Factor CTCF-L/BORIS

  2012cited by this paper
• Amplification of the 20q Chromosomal Arm Occurs Early in Tumorigenic Transformation and May Initiate Cancer

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Cancer-testis antigen, BORIS based vaccine delivered by dendritic cells is extremely effective against a very aggressive and highly metastatic mouse mammary carcinoma.

  2011cited by this paper
• The Cancer Stem Cell Hypothesis: Failures and Pitfalls

  2011cited by this paper
• Single nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcome

  2011cited by this paper
• Expression of the Epigenetic factor BORIS (CTCFL) in the Human Genome

  2011cited by this paper
• BORIS Binding to the Promoters of Cancer Testis Antigens, MAGEA2, MAGEA3, and MAGEA4, Is Associated with Their Transcriptional Activation in Lung Cancer

  2011cited by this paper
• CTCF and BORIS Regulate Rb2/p130 Gene Transcription: A Novel Mechanism and a New Paradigm for Understanding the Biology of Lung Cancer

  2011cited by this paper
• Analysis of Promoter Methylation and Polymorphic Minisatellites of BORIS and Lack of Association with Gastric Cancer

  2011cited by this paper
• Widespread Expression of BORIS/CTCFL in Normal and Cancer Cells

  2011cited by this paper
• Coordinated Cancer Germline Antigen Promoter and Global DNA Hypomethylation in Ovarian Cancer: Association with the BORIS/CTCF Expression Ratio and Advanced Stage

  2011cited by this paper
• Genome-wide copy number profiling using a 100K SNP array reveals novel disease-related genes BORIS and TSHZ1 in juvenile angiofibroma.

  2011cited by this paper
• Transcription Factor BORIS (Brother of the Regulator of Imprinted Sites) Directly Induces Expression of a Cancer-Testis Antigen, TSP50, through Regulated Binding of BORIS to the Promoter*

  2011cited by this paper
• Mutation Analysis of CCM1, CCM2 and CCM3 Genes in a Cohort of Italian Patients with Cerebral Cavernous Malformation

  2011cited by this paper
• Susceptibility for breast cancer in young patients with short rare minisatellite alleles of BORIS.

  2010cited by this paper
• Expression of a Testis-Specific Form of Gal3st1 (CST), a Gene Essential for Spermatogenesis, Is Regulated by the CTCF Paralogous Gene BORIS

  2010cited by this paper
• BORIS/CTCFL-mediated transcriptional regulation of the hTERT telomerase gene in testicular and ovarian tumor cells

  2010cited by this paper
• The Structural Complexity of the Human BORIS Gene in Gametogenesis and Cancer

  2010cited by this paper
• DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas

  2010cited by this paper
• BORIS (CTCFL) Is Not Expressed in Most Human Breast Cell Lines and High Grade Breast Carcinomas

  2010cited by this paper
• Epigenetic silencing of the p16(INK4a) tumor suppressor is associated with loss of CTCF binding and a chromatin boundary.

  2009cited by this paper
• Idiopathic male infertility is strongly associated with aberrant methylation of MEST and IGF2/H19 ICR1.

  2009cited by this paper

• Loss of miR-122 promotes cell migration and poor prognosis in triple-negative breast cancer treated by neoadjuvant chemotherapy.

  2025cites this paper